Search all trials

Find therapies in clinical trials near you – page 10

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Acute myeloid leukaemia

Recruiting

InvestigationalNo placebo

Study on the Safety and Effectiveness of Quizartinib for Children with Newly Diagnosed FLT3-ITD Positive AML and Normal NPM1

InvestigationalNo placebo

Spain

Participants:0–17 years · 18–64 years
Substances:Quizartinib Dihydrochloride

Contact Research Centre

Pneumonia

Recruiting

Investigational

Study of Trimodulin for Adults Hospitalized with Severe Community-Acquired Pneumonia

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Trimodulin (Human Igm, Iga, Igg Solution)

Contact Research Centre

Malignant melanoma

Recruiting

Registered drugNo placebo

Study to Compare Fianlimab and Cemiplimab Combination with Pembrolizumab in Patients with High-Risk Melanoma After Surgery

Registered drugNo placebo

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Cemiplimab

Contact Research Centre

Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

Recruiting

Registered drugNo placebo

Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Neuroendocrine tumour+1

Recruiting

Registered drugNo placebo

Study Comparing 177Lu-Edotreotide and Everolimus for Patients with Neuroendocrine Tumors in the Lung and Thymus

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Everolimus

Contact Research Centre

Hormone receptor positive breast cancer

Recruiting

Registered drugNo placebo

Study on Elacestrant and Triptorelin for Premenopausal Women with Early Luminal Breast Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Tamoxifen Citrate

Contact Research Centre

Plasma cell myeloma

Recruiting

Registered drugNo placebo

Study Comparing Iberdomide and Lenalidomide for Maintenance Therapy After Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

Dilated cardiomyopathy+1

Recruiting

Registered drug

Study on Early Use of Candesartan vs Placebo for People with Genetic Risk of Dilated Cardiomyopathy

Registered drug

Spain

Participants:18–64 years
Substances:Candesartan Cilexetil

Contact Research Centre

Study on Allogeneic Stem Cell Transplantation for Children and Adolescents with Acute Lymphoblastic Leukemia Using Etoposide, Treosulfan, and Thiotepa

Recruiting

Registered drugNo placebo

Study on Allogeneic Stem Cell Transplantation for Children and Adolescents with Acute Lymphoblastic Leukemia Using Etoposide, Treosulfan, and Thiotepa

Registered drugNo placebo

Spain

Participants:0–17 years · 18–64 years
Substances:Blinatumomab

Contact Research Centre

Antithrombin III deficiency

Recruiting

Registered drugNo placebo

Study on the Effectiveness of Atenativ for Patients with Congenital Antithrombin Deficiency Undergoing Surgery or Childbirth

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Antithrombin Iii Human

Contact Research Centre

Renal cell carcinoma

Recruiting

Registered drugNo placebo

Study on Durvalumab and Tremelimumab for Patients with Kidney Cancer at Risk of Recurrence After Surgery

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Neoplasm

Recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of ART0380 Alone or with Gemcitabine or Irinotecan for Patients with Advanced or Metastatic Solid Tumors

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Art0380 Mesilate

Contact Research Centre

Find therapies in clinical trials near you – page 10

310 trials match your criteria

Acute myeloid leukaemia

Study on the Safety and Effectiveness of Quizartinib for Children with Newly Diagnosed FLT3-ITD Positive AML and Normal NPM1

Pneumonia

Study of Trimodulin for Adults Hospitalized with Severe Community-Acquired Pneumonia

Malignant melanoma

Study to Compare Fianlimab and Cemiplimab Combination with Pembrolizumab in Patients with High-Risk Melanoma After Surgery

Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

Neuroendocrine tumour+1

Study Comparing 177Lu-Edotreotide and Everolimus for Patients with Neuroendocrine Tumors in the Lung and Thymus

Hormone receptor positive breast cancer

Study on Elacestrant and Triptorelin for Premenopausal Women with Early Luminal Breast Cancer

Plasma cell myeloma

Study Comparing Iberdomide and Lenalidomide for Maintenance Therapy After Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma

Dilated cardiomyopathy+1

Study on Early Use of Candesartan vs Placebo for People with Genetic Risk of Dilated Cardiomyopathy

Study on Allogeneic Stem Cell Transplantation for Children and Adolescents with Acute Lymphoblastic Leukemia Using Etoposide, Treosulfan, and Thiotepa

Study on Allogeneic Stem Cell Transplantation for Children and Adolescents with Acute Lymphoblastic Leukemia Using Etoposide, Treosulfan, and Thiotepa

Antithrombin III deficiency

Study on the Effectiveness of Atenativ for Patients with Congenital Antithrombin Deficiency Undergoing Surgery or Childbirth

Renal cell carcinoma

Study on Durvalumab and Tremelimumab for Patients with Kidney Cancer at Risk of Recurrence After Surgery

Neoplasm

Study on the Safety and Effectiveness of ART0380 Alone or with Gemcitabine or Irinotecan for Patients with Advanced or Metastatic Solid Tumors

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.